CORONA, Calif. The United States District Court for the Southern District of Florida ruled that Watson Pharmaceuticals’ naproxen sodium extended-release tablets, a generic version of the pain medication Naprelan, infringes the brand drug manufacturer’s patent, Watson announced Wednesday.
NEW BRUNSWICK, N.J. Johnson & Johnson’s subsidiary Ortho Biotech is recalling more than 44,000 vials of the erythropoiesis-stimulating agent Procrit because its post-manufacturing inspection found cracks in a small number of vials.
MELBOURNE, Australia Transdermal drug device company Acrux has signed a licensing deal with KV Pharmaceuticals to bring its menopause symptom product to the United States, according to published reports.
What area is your company focused most on in 2019?